195 related articles for article (PubMed ID: 16231000)
1. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
[TBL] [Abstract][Full Text] [Related]
3. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
5. NPY receptor subtype in the rabbit isolated ileum.
Félétou M; Nicolas JP; Rodriguez M; Beauverger P; Galizzi JP; Boutin JA; Duhault J
Br J Pharmacol; 1999 Jun; 127(3):795-801. PubMed ID: 10401572
[TBL] [Abstract][Full Text] [Related]
6. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
Widdowson PS
Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
[TBL] [Abstract][Full Text] [Related]
7. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic reevaluation of the binding properties of 125I-[Leu31,Pro34]peptide YY and 125I-peptide YY3-36 to neuropeptide Y receptor subtypes in rat forebrain.
Gobbi M; Mennini T; Vezzani A
J Neurochem; 1999 Apr; 72(4):1663-70. PubMed ID: 10098875
[TBL] [Abstract][Full Text] [Related]
9. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
Dumont Y; Jacques D; Bouchard P; Quirion R
J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905
[TBL] [Abstract][Full Text] [Related]
10. Novel analogues of neuropeptide Y with a preference for the Y1-receptor.
Söll RM; Dinger MC; Lundell I; Larhammer D; Beck-Sickinger AG
Eur J Biochem; 2001 May; 268(10):2828-37. PubMed ID: 11358498
[TBL] [Abstract][Full Text] [Related]
11. [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors.
Gehlert DR; Schober DA; Gackenheimer SL; Beavers L; Gadski R; Lundell I; Larhammar D
Peptides; 1997; 18(3):397-401. PubMed ID: 9145427
[TBL] [Abstract][Full Text] [Related]
12. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
Umeda T; Kanatani A; Iwaasa H
Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
[TBL] [Abstract][Full Text] [Related]
14. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
Schober DA; Van Abbema AM; Smiley DL; Bruns RF; Gehlert DR
Peptides; 1998; 19(3):537-42. PubMed ID: 9533642
[TBL] [Abstract][Full Text] [Related]
15. NPY-induced feeding involves the action of a Y1-like receptor in rodents.
Kanatani A; Ito J; Ishihara A; Iwaasa H; Fukuroda T; Fukami T; MacNeil DJ; Van der Ploeg LH; Ihara M
Regul Pept; 1998 Sep; 75-76():409-15. PubMed ID: 9802437
[TBL] [Abstract][Full Text] [Related]
16. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents.
Parker SL; Parker MS
Regul Pept; 2000 Feb; 87(1-3):59-72. PubMed ID: 10710289
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors.
Parker SL; Parker MS; Crowley WR
Regul Pept; 1998 Sep; 75-76():127-43. PubMed ID: 9802402
[TBL] [Abstract][Full Text] [Related]
18. Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Dautzenberg FM; Neysari S
Pharmacology; 2005 Dec; 75(1):21-9. PubMed ID: 15908753
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
20. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]